Draximage Dtpa Injection, Powder, Lyophilized, For Solution
Product Images NDC 65174-288

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Draximage Dtpa (NDC 65174-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Vials Carton (Dtpa 30 Vial Carton)

Packaging label for DRAXIMAGE DTPA Kit for the Preparation of Technetium Tc 99m Pentetate Injection 20 mg/vial. The label includes instructions for intravenous and inhalation use, cautionary statements, and storage information. Manufactured by Jubilant DraxImage Inc., dba Jubilant Radiopharma. The label shows the product NDC 65174-288 and highlights that it is a multi-dose diagnostic kit for radiopharmaceutical use.*

FDA Label Image

Vial Label (Dtpa Vial Label)

Label for DRAXIMAGE DTPA 20 mg/vial, a kit for the preparation of Technetium Tc 99m Pentetate Injection. The label states it is a multi-dose, sterile, non-pyrogenic product for intravenous and inhalation use, containing pentetic acid and other components. Manufactured by Jubilant DraxImage Inc., Kirkland, Quebec, Canada. Includes storage and handling instructions and NDC 65174-288.*

FDA Label Image

Eq1 (Eq1)

A mathematical formula image showing the calculation for Percent 99mTcO2, expressed as counts in Part I divided by the counts in Part I plus Part II, multiplied by 100.*

FDA Label Image

Eq2 (Eq2)

The image shows a chemical formula representing the calculation for the percent of Technetium-99m pertechnetate ion (99mTcO4-) based on counts in specific parts labeled Part III and Part IV. It is related to the analysis or preparation involving Draximage DTPA, a kit for Technetium Tc 99m Pentetate.*

FDA Label Image

Figure_1 (Figure 1)

An instructional diagram showing a vial and preparation steps for DRAXIMAGE DTPA injection, powder, lyophilized, for solution. It depicts adding saline to the vial and cutting a strip 3 cm long divided into two parts: Part I containing reduced hydrolyzed technetium and Part II containing 99mTc O4- and bound technetium.*

FDA Label Image

Figure2 (Figure 2)

An instructional diagram showing a step in a laboratory procedure involving cutting and separating parts of a sample tube. The diagram marks a cut at 2 cm and identifies Part III (99mTc O4-) and Part IV (bound 99mTc and reduced hydrolyzed technetium). Acetone and a 1.5 cm measurement are also indicated.*

FDA Label Image

Radioactive Label (Radioactive Label)

Label for Technetium Tc 99m Pentetate Injection, a multi-dose diagnostic product for intravenous and inhalation use. The label includes fields for total activity in MBq and mCi, volume in mL, and concentration. It cautions storage at 25°C in a lead shield after labeling with oxidant-free technetium Tc-99m and use within 12 hours. Manufacturer information for Jubilant DraxImage Inc. in Kirkland, Quebec, Canada, is shown, along with a radioactive material caution symbol.*

FDA Label Image

Step-6-formula (Step 6 Formula)

A formula depicting percentage bound of Technetium Tc 99m calculated as 100 minus the sum of percentages of TcO4- and TcO2 species.*

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient in DRAXIMAGE DTPA Kit for the preparation of Technetium Tc 99m Pentetate, showing the coordination complex with Tc-99m and the chelating pentetate ligand with carboxylate groups and amine nitrogen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.